Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 408 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Supplementary Table S11 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial
Petros Grivas,Elena Garralda, Funda Meric-Bernstam,Ingo K. Mellinghoff,Lipika Goyal,James J. Harding, E. Claire Dees,Rastislav Bahleda, Nilofer S. Azad, Asha Karippot,Razelle Kurzrock,Josep Tabernero, Juha Kononen, Matthew C.H. Ng, Rutika Mehta, Nataliya V. Uboha, Frédéric Bigot,Valentina Boni, Samantha E. Bowyer,Valeriy Breder,Andrés Cervantes,Nancy Chan, James M. Cleary, Mallika Dhawan, Rikke L. Eefsen, James Ewing, Donna M. Graham,Tormod K. Guren, Jin Won Kim, Krassimir Koynov, Do-Youn Oh,Rebecca Redman,Chia-Jui Yen, David Spetzler, Marie-Claude Roubaudi-Fraschini, Valerie Nicolas-Metral, Rafik Ait-Sarkouh,Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T. Flaherty
crossref（2024）
Cited0Views0Bibtex
0
0
Evolution of Phase 1 Clinical Trials for Head and Neck Cancer Patients Based on the Experience of a Dedicated Phase I Unit
Katerin Rojas,Alberto Hernando, Juan Assaf, Eduardo Garcia, Maria Vieito,Vladimir Galvao,Omar Saavedra,Guzman Alonso,Julia Lostes,Mafalda Oliveira, Oriol Mirallas, Arjun Oberoi, Giulia Pretelli, Belen Ortega, Raquel Granados,Jordi Giralt,Coro Bescos,Juan Lorente, Sahyly Siurana, Joseph Tabernero,Ana Oaknin,Enriqueta Felip,Elena Garralda,Irene Brana
RADIOTHERAPY AND ONCOLOGY (2024): S171-S172
Cited0Views0Bibtex
0
0
A Phase 2, Multicenter Study of TILs Treatment in Advanced Tumors with Alterations in the SWI/SNF Complex: the TILTS Study
Juan Martin-Liberal,Elena Garralda, Jesus Garcia Donas, Juan Jose Soto, Carles Codony, Silvia Mart Prime In-Lluesma, Susana Munoz,Vladimir Galvao, M. Julia Lostes-Bardaji, Marta Rotxes, Sergio Querol, Luciano Rodriguez, Ainhoa Munoz,Rafael Moreno, Xavier Garcia del Muro,Ramon Alemany,Alena Gros, Josep M. Piulats
Journal of Clinical Oncologyno. 16_suppl (2024): TPS2674-TPS2674
Cited0Views0Bibtex
0
0
675 VICTORIA-01: a Multicenter, Open-Label, Phase 1 Study to Evaluate the Safety and Preliminary Efficacy of SOT201 in Patients with Advanced or Metastatic Solid Tumors
Aung Naing,Elena Garralda,Bohuslav Melichar, Nuria Kotecki, Hans Prenen, Yoselin Grimaldi, Stanislav Katina, Richard Sachse, Radka Obermannova
Regular and Young Investigator Award Abstracts (2024)
Cited0Views0Bibtex
0
0
A Phase I Monotherapy Dose Escalation Study of HFB301001, a Novel Next Generation OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Anthony B. El-Khoueiry,Elena Garralda,Andres Cervantes, Candace L. Haddox, Hani M. Babiker,Mitesh J. Borad,Konstantinos Leventakos,Ranee Mehra,Jon Zugazagoitia, Diana L. Hanna,Guzman Alonso, Angela Liu, Xiaorong Shi, Jack Russella Pollard, Gabrielle Wong, William Hedrich, Xi Lin,Christos Hatzis, John Pallante, Robert H. Andtbacka
Journal of Clinical Oncologyno. 16_suppl (2024): 2531-2531
Cited0Views0Bibtex
0
0
Safety and Clinical Activity of JNJ-78306358, a Human Leukocyte Antigen-G (HLA-G) X CD3 Bispecific Antibody, for the Treatment of Advanced Stage Solid Tumors
Ravit Geva,Maria Vieito, Jorge Ramon,Ruth Perets,Manuel Pedregal,Elena Corral,Bernard Doger,Emiliano Calvo, Jorge Bardina,Elena Garralda,Regina J. Brown,James G. Greger, Shujian Wu, Douglas Steinbach, Tsun-Wen Sheena Yao, Yu Cao,Josh Lauring, Ruchi Chaudhary, Jaymala Patel, Bharvin Patel,Victor Moreno
CANCER IMMUNOLOGY IMMUNOTHERAPYno. 10 (2024)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 407

#Citation: 5166

H-Index: 36

G-Index: 70

Sociability: 8

Diversity: 0

Activity: 7

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn